Entities / Company
Medtronic plc.
medical device company
- Reports this week
- 3
- Active events
- 2
- Connections
- 211
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
-
Wolfe Research upgraded Medtronic's stock rating on July 4, 2025, coinciding with the company announcing the integration of the Affera platform.Speculative3 reports
-
MarketBeat listed Danaher, Dexcom, Medtronic, Gilead Sciences, and Boston Scientific as stocks to watch on September 22, 2026.Some support1 report
Earlier this month
-
Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.Some support2 reports12 developments inside
-
Medtronic plc is a global healthcare technology company headquartered in Galway, Ireland, with executives including Thierry Piéton and Greg Smith.Well supported13 reports1 development inside
-
Medtronic announced it began its first surgical procedures in Europe, utilizing its advanced surgical systems in an Irish hospital.Some support1 report
-
Medtronic expands its Hugo system via investment and Jim Cramer views the company as a quandary stock.Some support2 reports
-
Stryker Corporation, Boston Scientific, and Medtronic plc are competing in the medical device market.Some support3 reports1 development inside
One to three months ago
-
Medtronic plc, Intuitive Surgical, Inc., and Abbott Laboratories are leaders in medical device technology and are currently facing market valuation pressures.Some support1 report
-
Medtronic acquired Given Imaging, and the FDA published an early alert regarding a product recall.Speculative1 report1 development inside
-
Johnson & Johnson, Medtronic plc, and Omega Healthcare are noted as major medical device makers and dividend-paying healthcare stocks.Some support4 reports4 developments inside
-
Medtronic plc announced a collaboration with Orchestra BioMed Holdings to develop and commercialize AVIM therapy.Some support3 reports
-
Analysts at Wells Fargo raised price targets for Medtronic, while UBS analysts provided bullish notes on the company's prospects.Well supported3 reports
-
Medtronic plc announced it is seeking an expedited regulatory pathway for a technology.Some support2 reports
-
FDA granted clearance for Hugo's Instrument Exit Point, while CAS was expected to grow mid-to-high teens.Some support1 report
-
Market growth in the medical device sector, driven by cardiovascular disease trends, involving multiple companies like LivaNova, Medtronic, and Philips in Europe.Some support1 report1 development inside
-
Leerink partners adjusted its rating and target price for Medtronic plc on July 31, 2026.Some support1 report
-
Surgical-robot competition from Intuitive Surgical.Some support3 reports1 development inside
-
California State Teachers Retirement System trimmed its position in Medtronic shares and filed reports with the SEC.Some support2 reports
-
Citigroup cut its target price on Medtronic stock, and TD Cowen also lowered its price target for the company.Some support7 reports
-
Medtronic and Boston Scientific are expanding globally into emerging markets, operating in the MedSurg equipment space.Speculative1 report1 development inside
-
RETIA expanded its commercial relationship for distribution with Medtronic plc on July 1, 2026.Some support1 report
-
Institutional investors filed reports with the SEC regarding Medtronic plc.Some support1 report2 developments inside
-
Smithbridge Asset Management trimmed its holdings in Medtronic stock and filed a disclosure with the SEC.Some support7 reports
Gone quiet
No new reports in 90+ days-
Medtronic received a 'Buy' rating from TD Cowen, bolstered by favorable CMS coverage terms and the tailwinds of Trump-era tariffs benefiting AI stocks.Some support2 reports1 development inside
-
Medtronic plc filed required reports with the Securities and Exchange Commission.Some support6 reports
-
Analyst rating and price target updates for Medtronic, alongside required institutional investment disclosures filed with the SEC.Some support1 report
-
State of Wisconsin Investment Board cut its stake in Medtronic while SageView Advisory Group increased its stake.Some support1 report
-
David Roman trimmed the price target for Medtronic plc on June 15, 2026.Some support1 report
-
Truist Financial lowered its price objective for Medtronic plc stock.Some support1 report
-
Illinois Municipal Retirement Fund boosted its position in Medtronic shares.Some support1 report
-
Medtronic announced its intention to acquire SPR Therapeutics, while Goldman Sachs reinstated its coverage of Medtronic with a Neutral rating.Some support1 report
-
GE Healthcare, Medtronic plc, and Integra LifeSciences were identified as key players in the market as of August 21, 2025.Some support1 report
-
Stryker received FDA 510(k) clearance for its OptaBlate system, and Medtronic received clearance for OsteoCool 2.0.Some support2 reports
-
General Electric, Medtronic plc, and Philips are leading players in the anaesthesia devices market and are anticipated to drive growth in the Asia-Pacific region.Speculative1 report
-
Philips, Medtronic, and Abbott Japan are identified as key players in the Remote Patient Monitoring (RPM) market.Some support1 report
-
Medtronic plc is facing activist pressure from investors, leading to the appointment of an interim CEO, former CFO, and former CEO to the company board.Some support3 reports1 development inside
-
Medtronic appointed Dr. Joon Lee to its Board of Directors, whose qualifications include 25 years at UPMC, training at MGH, and certification by ABIM.Speculative1 report
-
Medtronic plans to integrate with Abbott’s Libre sensors as both firms develop multi-analyte sensor technology.Speculative1 report1 development inside
-
FDA granted regulatory milestones to Medtronic, which is integrating with Abbott's Instinct sensor.Well supported3 reports2 developments inside
-
Agilent Technologies and Medtronic plc were noted to operate within the same industry.Speculative1 report
-
Medical device companies are advancing their products and market presence, including Intuitive Surgical leadership updates, market entry for Moon Surgical and CMR Surgical, and regulatory milestones for Medtronic in Europe.Speculative1 report2 developments inside
-
Alexander Zverev and Medtronic plc have formed a partnership aimed at raising awareness about diabetes.Speculative1 report
-
Medtronic is emerging as a strong competitor to Intuitive Surgical amid a surge in SP procedures, with Korea leading utilization.Some support7 reports
-
Philips and Medtronic expanded their collaboration to advance patient monitoring technologies.Some support5 reports
-
Medtronic is preparing for the spin-off of its MiniMed business unit, and Chad Spooner has been appointed as the new CFO of the entity.Some support4 reports
-
Trump's trade agenda and tariffs are currently impacting Medtronic plc.Speculative1 report
-
A summary of industry trends from July 11, 2025, noting the Humira patent expiration, Johnson & Johnson's consistency, and Medtronic's dividend increases.Some support2 reports
-
Intuitive Surgical and Medtronic participated in a telesurgery demonstration involving personnel from both companies, held in Strasbourg, France, with a console in Georgia.Some support1 report
-
Medtronic plc supports SpineHope's medical missions in Nicaragua, where Monica Santamaria resided.Some support1 report
-
Carlsmed's custom medical devices are entering a competitive market against products from Johnson & Johnson, Globus Medical, and Medtronic plc.Some support1 report
-
Medtronic plc secured the CE Mark for its MiniMed™ 780G system in Europe.Some support1 report
-
Market growth in the Urology Care Devices & Platforms Market is being driven by advanced diagnostics and procedures.Some support2 reports1 development inside
-
Medtronic's TAVR systems were found to infringe on Colibri's patented method, but the ruling was overturned by the US Court of Appeals.Some support1 report
-
Abbott Laboratories, Medtronic plc, and Merck KGaA are key players in the Cardiac Tissue Engineering Market.Some support1 report
-
Johnson & Johnson and Medtronic are noted as good dividend stocks while also dealing with a huge class-action lawsuit.Some support2 reports
-
BDX, Medtronic plc, and Universal Health Services are discussed as dividend-paying stocks.Some support1 report
-
Medtronic competes in the medical device market against Johnson & Johnson and is receiving institutional backing from major financial firms including BlackRock, Vanguard, and State Street.Some support1 report
-
Abbott Laboratories and Medtronic plc operate within the healthcare device sector.Well supported7 reports
-
Medtronic is developing a robotic-assisted surgery system that needs regulatory approval in the US, amidst aggressive trade policy threats.Some support2 reports
-
Medtronic invested in Orchestra BioMed's clinical programs and provided private placement funding, while Ligand also invested in the company.Some support3 reports
No events began in the chosen period. Widen it, or reset.
Around Medtronic plc this week
News at the entities that move Medtronic plc most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Medtronic plc
-
Ireland StructuralIreland is working to improve governmental transparency by enhancing its digital services.Moves Medtronic plc
-
Elliott Investment Management StructuralGold Fields approached Northern Star Resources regarding a potential takeover, amidst activist investor pressure regarding performance.Moves Medtronic plc
-
Food and Drug Administration StructuralIn 2007, CBS broadcast featured Andrews, Cordes, and Couric criticizing the Food and Drug Administration's problems.Moves Medtronic plc
-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Medtronic plc
-
Medicare OperationalLeaders call for slowing AI development pace, concurrent with an AI model built by OpenAI being hacked via the Medicare portal.Moves Medtronic plc
Connections
The 40 strongest of 211, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Securities and Exchange Commission Structural
Medtronic plc is formally required to file periodic reports and disclosures with the SEC as part of its ongoing regulatory compliance.
-
Ireland Structural
Medtronic plc is incorporated and headquartered in Ireland, establishing a foundational structural base.
-
Elliott Investment Management Structural
Elliott Investment Management exerts activist pressure as a major shareholder, influencing Medtronic's board and strategic focus.
-
Thierry Piéton Structural
Thierry Piéton holds an executive position, including CFO, at Medtronic plc.
-
FDA Structural
The FDA formally regulates Medtronic's medical devices, granting clearances, approvals, and managing recalls.
-
SEC Structural
Medtronic plc is subject to formal regulatory oversight and reporting requirements by the SEC.
-
Intuitive Surgical Operational
Intuitive Surgical and Medtronic plc are active competitors in the robotic-assisted surgery and medical device market.
-
Food and Drug Administration Structural
The FDA formally regulates Medtronic plc, issuing recalls and alerts regarding product safety.
Show all 40 connections
-
Royal National Orthopaedic Hospital Structural
Medtronic supplies surgical systems to the Royal National Orthopaedic Hospital.
-
Illinois Municipal Retirement Fund Transactional
The fund increased its investment holdings in Medtronic plc shares.
-
Johnson & Johnson Operational
Johnson & Johnson and Medtronic are direct competitors and major players in the medical device market.
-
Medicare Operational
Medtronic operates within the market governed by Medicare, which imposes specific reimbursement constraints on its products and services.
-
Leerink partners Mentioned together
Leerink partners provides market research and analysis on Medtronic plc's stock performance.
-
Truist Financial Transactional
Truist Financial lowered its price objective on Medtronic plc stock.
-
Capital Research Global Investors Transactional
Capital Research Global Investors boosted its position in Medtronic plc, resulting in a 12.6% increase in valuation during the 4th quarter.
-
Donald Trump Structural
Donald Trump's trade policies and tariffs directly affect Medtronic plc.
-
Stryker Corporation Operational
Stryker Corporation and Medtronic plc are competitors operating within the medical device market.
-
Boston Scientific Operational
The companies are direct competitors operating within the medical device manufacturing sector.
-
RETIA Operational
The relationship is characterized by an ongoing, expanded commercial partnership focused on market distribution.
-
representative Transactional
The representative sold Medtronic plc stock in a transaction valued between $1,001 and $15,000.
-
BofA Securities, Inc. Transactional
BofA Securities acted as dealer manager for Medtronic's exchange offer.
-
Citigroup Mentioned together
Citigroup has issued a target price recommendation regarding Medtronic stock.
-
Abbott Laboratories Operational
Both Abbott and Medtronic are identified as key competitors and players within the healthcare device and tissue engineering markets.
-
State of Wisconsin Investment Board Transactional
The State of Wisconsin Investment Board reduced its investment stake in Medtronic plc.
-
SageView Advisory Group Transactional
SageView Advisory Group increased its investment stake in Medtronic plc.
-
Invest Mentioned together
The entities are co-mentioned in the context of stock performance and investment appeal.
-
MarketBeat Mentioned together
MarketBeat tracks and reports on Medtronic's stock performance and financial status using its financial tools.
-
Galway Shared context
Medtronic plc is headquartered in the city of Galway.
-
Jacob Greenberg Operational
Jacob Greenberg led a study evaluating Medtronic's Hugo system.
-
TD Cowen Mentioned together
TD Cowen provides sell-side analyst coverage, including ratings and price target updates, for Medtronic plc.
-
Minnesota Shared context
Legacy Medtronic was incorporated in Minnesota.
-
China Shared context
Medtronic operates within the market and regulatory context of China, specifically regarding surgical systems co-distribution.
-
Hugo Operational
The relationship is characterized by Medtronic's investment in and expansion of the Hugo system, indicating an active functional partnership.
-
Morgan Stanley Mentioned together
Morgan Stanley provides professional market coverage and price targets for Medtronic plc.
-
Alexandria Real Estate Equities Mentioned together
The companies are co-mentioned in articles highlighting their status as high-yield dividend stocks.
-
Bank of America Mentioned together
Bank of America issues research reports analyzing Medtronic plc.
-
Emory Healthcare Mentioned together
The two companies are linked by shared personnel, as a former Emory Healthcare CEO joined the Medtronic plc board.
-
Jim Cramer Mentioned together
Jim Cramer provides market commentary and warnings regarding Medtronic's stock status and strategic issues.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group issued a 'hold' rating and set an $88 price target for Medtronic plc.
-
Royal Bank of Canada Mentioned together
Royal Bank of Canada provides financial analysis, including ratings and price targets, for Medtronic plc.
History
Events by the month they beganSeptember 2026
3 events- MarketBeat listed Danaher, Dexcom, Medtronic, Gilead Sciences, and Boston Scientific as stocks to watch on September 22, 2026.
- Medtronic announced it began its first surgical procedures in Europe, utilizing its advanced surgical systems in an Irish hospital.
- Medtronic expands its Hugo system via investment and Jim Cramer views the company as a quandary stock.
August 2026
4 events- Stryker Corporation, Boston Scientific, and Medtronic plc are competing in the medical device market.
- Medtronic plc, Intuitive Surgical, Inc., and Abbott Laboratories are leaders in medical device technology and are currently facing market valuation pressures.
- Medtronic plc announced it is seeking an expedited regulatory pathway for a technology.
- FDA granted clearance for Hugo's Instrument Exit Point, while CAS was expected to grow mid-to-high teens.
July 2026
5 events- Leerink partners adjusted its rating and target price for Medtronic plc on July 31, 2026.
- California State Teachers Retirement System trimmed its position in Medtronic shares and filed reports with the SEC.
- Citigroup cut its target price on Medtronic stock, and TD Cowen also lowered its price target for the company.
- RETIA expanded its commercial relationship for distribution with Medtronic plc on July 1, 2026.
- Smithbridge Asset Management trimmed its holdings in Medtronic stock and filed a disclosure with the SEC.
Show 1 earlier month
June 2026
48 events- Wolfe Research upgraded Medtronic's stock rating on July 4, 2025, coinciding with the company announcing the integration of the Affera platform.
- Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.
- Medtronic plc is a global healthcare technology company headquartered in Galway, Ireland, with executives including Thierry Piéton and Greg Smith.
- Medtronic acquired Given Imaging, and the FDA published an early alert regarding a product recall.
- Johnson & Johnson, Medtronic plc, and Omega Healthcare are noted as major medical device makers and dividend-paying healthcare stocks.
- Medtronic plc announced a collaboration with Orchestra BioMed Holdings to develop and commercialize AVIM therapy.
- Analysts at Wells Fargo raised price targets for Medtronic, while UBS analysts provided bullish notes on the company's prospects.
- Market growth in the medical device sector, driven by cardiovascular disease trends, involving multiple companies like LivaNova, Medtronic, and Philips in Europe.
- Surgical-robot competition from Intuitive Surgical.
- Medtronic and Boston Scientific are expanding globally into emerging markets, operating in the MedSurg equipment space.
- Institutional investors filed reports with the SEC regarding Medtronic plc.
- Medtronic received a 'Buy' rating from TD Cowen, bolstered by favorable CMS coverage terms and the tailwinds of Trump-era tariffs benefiting AI stocks.
- Medtronic plc filed required reports with the Securities and Exchange Commission.
- Analyst rating and price target updates for Medtronic, alongside required institutional investment disclosures filed with the SEC.
- State of Wisconsin Investment Board cut its stake in Medtronic while SageView Advisory Group increased its stake.
- David Roman trimmed the price target for Medtronic plc on June 15, 2026.
- Truist Financial lowered its price objective for Medtronic plc stock.
- Illinois Municipal Retirement Fund boosted its position in Medtronic shares.
- Medtronic announced its intention to acquire SPR Therapeutics, while Goldman Sachs reinstated its coverage of Medtronic with a Neutral rating.
- GE Healthcare, Medtronic plc, and Integra LifeSciences were identified as key players in the market as of August 21, 2025.
- Stryker received FDA 510(k) clearance for its OptaBlate system, and Medtronic received clearance for OsteoCool 2.0.
- General Electric, Medtronic plc, and Philips are leading players in the anaesthesia devices market and are anticipated to drive growth in the Asia-Pacific region.
- Philips, Medtronic, and Abbott Japan are identified as key players in the Remote Patient Monitoring (RPM) market.
- Medtronic plc is facing activist pressure from investors, leading to the appointment of an interim CEO, former CFO, and former CEO to the company board.
- Medtronic appointed Dr. Joon Lee to its Board of Directors, whose qualifications include 25 years at UPMC, training at MGH, and certification by ABIM.
- Medtronic plans to integrate with Abbott’s Libre sensors as both firms develop multi-analyte sensor technology.
- FDA granted regulatory milestones to Medtronic, which is integrating with Abbott's Instinct sensor.
- Agilent Technologies and Medtronic plc were noted to operate within the same industry.
- Medical device companies are advancing their products and market presence, including Intuitive Surgical leadership updates, market entry for Moon Surgical and CMR Surgical, and regulatory milestones for Medtronic in Europe.
- Alexander Zverev and Medtronic plc have formed a partnership aimed at raising awareness about diabetes.
- Medtronic is emerging as a strong competitor to Intuitive Surgical amid a surge in SP procedures, with Korea leading utilization.
- Philips and Medtronic expanded their collaboration to advance patient monitoring technologies.
- Medtronic is preparing for the spin-off of its MiniMed business unit, and Chad Spooner has been appointed as the new CFO of the entity.
- Trump's trade agenda and tariffs are currently impacting Medtronic plc.
- A summary of industry trends from July 11, 2025, noting the Humira patent expiration, Johnson & Johnson's consistency, and Medtronic's dividend increases.
- Intuitive Surgical and Medtronic participated in a telesurgery demonstration involving personnel from both companies, held in Strasbourg, France, with a console in Georgia.
- Medtronic plc supports SpineHope's medical missions in Nicaragua, where Monica Santamaria resided.
- Carlsmed's custom medical devices are entering a competitive market against products from Johnson & Johnson, Globus Medical, and Medtronic plc.
- Medtronic plc secured the CE Mark for its MiniMed™ 780G system in Europe.
- Market growth in the Urology Care Devices & Platforms Market is being driven by advanced diagnostics and procedures.
- Medtronic's TAVR systems were found to infringe on Colibri's patented method, but the ruling was overturned by the US Court of Appeals.
- Abbott Laboratories, Medtronic plc, and Merck KGaA are key players in the Cardiac Tissue Engineering Market.
- Johnson & Johnson and Medtronic are noted as good dividend stocks while also dealing with a huge class-action lawsuit.
- BDX, Medtronic plc, and Universal Health Services are discussed as dividend-paying stocks.
- Medtronic competes in the medical device market against Johnson & Johnson and is receiving institutional backing from major financial firms including BlackRock, Vanguard, and State Street.
- Abbott Laboratories and Medtronic plc operate within the healthcare device sector.
- Medtronic is developing a robotic-assisted surgery system that needs regulatory approval in the US, amidst aggressive trade policy threats.
- Medtronic invested in Orchestra BioMed's clinical programs and provided private placement funding, while Ligand also invested in the company.